Related Experiment Video
Updated: Jul 13, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
The normal counterpart to the chronic lymphocytic leukemia B cell
Federico Caligaris-Cappio1, Paolo Ghia
1Department of Oncology, Lymphoma Unit, Università Vita-Salute San Raffaele and Istituto Scientifico San Raffaele, Via Olgettina 58, 20132 Milano, Italy. caligaris.federico@hsr.it
Chronic lymphocytic leukemia (CLL) involves abnormal B cell growth. This review explores the characteristics of a normal B cell that could be the origin of CLL, aiding disease understanding.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Chronic lymphocytic leukemia (CLL) is defined by the monoclonal expansion of mature B cells.
- CLL cells exhibit phenotypic homogeneity, co-expressing CD5 and CD23 with low surface immunoglobulin levels.
- Gene expression profiling supports a common pathogenic mechanism for CLL.
Purpose of the Study:
- To review the defining features of B cells that may serve as the normal counterpart to CLL B cells.
- To address the long-standing question regarding the cell of origin for CLL.
Main Methods:
- Review of existing literature on CLL cell biology and B cell development.
- Analysis of phenotypic and genotypic data of CLL cells.
- Comparison of CLL cell characteristics with potential normal B cell precursors.
Main Results:
- CLL cells are characterized by specific surface markers (CD5, CD23) and low surface immunoglobulin expression.
- Despite phenotypic homogeneity, the precise cell of origin remains elusive.
- The review discusses potential normal B cell populations that share key features with CLL cells.
Conclusions:
- Identifying the normal counterpart of CLL B cells is crucial for understanding disease pathogenesis.
- Further research is needed to definitively pinpoint the cell of origin.
- Understanding the origin may lead to novel therapeutic strategies for chronic lymphocytic leukemia.
More Related Videos
Related Concept Videos
Cells of the Adaptive Immune Response
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Lymphoid Cells and Tissues
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...

